Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Taxes (2016 - 2020)

China Pharma Holdings (CPHI) has disclosed Change in Taxes for 11 consecutive years, with -$155827.0 as the latest value for Q3 2020.

  • For the quarter ending Q3 2020, Change in Taxes fell 332.74% year-over-year to -$155827.0, compared with a TTM value of $113571.0 through Sep 2020, up 1315.18%, and an annual FY2019 reading of $12971.0, up 108.82% over the prior year.
  • Change in Taxes was -$155827.0 for Q3 2020 at China Pharma Holdings, down from $227245.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $227245.0 in Q2 2020 and bottomed at -$163335.0 in Q1 2018.
  • Average Change in Taxes over 5 years is $4244.9, with a median of -$10350.0 recorded in 2019.
  • The sharpest move saw Change in Taxes crashed 711.18% in 2017, then surged 2655.49% in 2020.
  • Year by year, Change in Taxes stood at $146187.0 in 2016, then plummeted by 88.35% to $17034.0 in 2017, then tumbled by 291.78% to -$32667.0 in 2018, then surged by 68.32% to -$10350.0 in 2019, then tumbled by 1405.57% to -$155827.0 in 2020.
  • Business Quant data shows Change in Taxes for CPHI at -$155827.0 in Q3 2020, $227245.0 in Q2 2020, and $52503.0 in Q1 2020.